144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial

Journal:

Journal of Hepatology

Published:

2026-04-09

DOI:

10.1016/j.jhep.2026.03.046

Affiliations:

25

Authors:

25

Go to article

Institutions	Authors	Share
Gilead, United States of America (USA)	7.000000	0.28
University Hospital Frankfurt, GU, Germany	2.000000	0.08
Karolinska University Hospital, Sweden	1.000000	0.04
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany	1.000000	0.04
M.F. Vladimirsky Moscow Regional Research and Clinical Institute (MONIKI), Russia	1.000000	0.04
National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Russia	1.000000	0.04
Stavropol Regional Clinical Hospital, Russia	1.000000	0.04
Hepatologist Medical Company, Samara, Russia	1.000000	0.04
South Ural State Medical University, Russia	1.000000	0.04
Modern Medicine Clinic, LLC, Russia	1.000000	0.04
German Center for Infection Research (DZIF), Germany	1.000000	0.04
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany	1.000000	0.04
Hannover Medical School (MHH), Germany	0.500000	0.02
Cluster of Excellence RESIST (EXC 2155), Germany	0.500000	0.02
D-SOLVE: EU-Funded Network on Individualized Management of Hepatitis D, Germany	0.500000	0.02
DZIF Partner Site Hannover-Braunschweig, Germany	0.500000	0.02
University of Modena and Reggio Emilia (UNIMORE), Italy	0.500000	0.02
Baggiovara General Hospital, Italy	0.500000	0.02
I.M. Sechenov First Moscow State Medical University (FMSMU), Russia	0.500000	0.02
Engelhardt Institute of Molecular Biology (EIMB), RAS, Russia	0.500000	0.02
University Hospital of Pisa, UNIPI, Italy	0.500000	0.02
University of Pisa (UNIPI), Italy	0.500000	0.02
IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Italy	0.500000	0.02
University of Milan (UNIMI), Italy	0.500000	0.02

Interested in Medical Microbiology?